Thu, Nov 12, 2026 - Page 19
13819 indexed SquawkNews stories from this UTC day. Showing 2161-2280.
L
CV Sciences Q3 revenue falls 7% amid regulatory pressure
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
SKYX Reports Record Revenue of $25.7M in Q-3 2026 Compared to $23.9M in Q-3 2025 and 11 Consecutive Quarters of Growth YoY
Gross profit rises in Q-3 by 11% to a record $8.1 million as SKYX continues to expand its market penetrationCompany maintains a strong cash position with $21 million in cash, cash equivalents and restricted cash at Septe
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Jefferson Capital Reports Third Quarter 2026 Results
Record Collections Grow 35% to $319.2 Million and Deployments grow 111% to $318.0 MillionRecord Estimated Remaining Collections (“ERC”) up 23% to $3.6 BillionPre-tax Income of $58.9 Million with Net Income of $46.9 Milli
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
INNOVATE Corp. (VATE) Reports Q3 Results Amid Asset Sales
INNOVATE announced third-quarter 2026 results, the sale of a controlling interest in HC2 Broadcasting, and the sale of DBM Global to IES Holdings shortly after quarter-end. The release provides no financial results figur
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Arcadia Biosciences Q3 revenue rises 24% to record high
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand
Hospital revenue grew sequentially to $6.8 million; customers purchasing two or more product lines up 14% from the second quarterIn-house production of Neox® and Clarix® on track to begin in the first half of 2027Raises
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Financial Results
Company Delivers 24% Q3 Revenue Growth and Returns to Positive Operating IncomeFREDERICK, Md., Nov. 12, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. NASDAQ:TOMZ, a global provider of disinfection and decon
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
MDxHealth's Q3 revenue misses expectations due to disrupted commercial execution
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:13 PM UTC
M
Cisco Systems Fiscal Q1 Adjusted Earnings and Revenue Rise; Sets Q2 Guidance
Cisco reported higher adjusted earnings and revenue for fiscal Q1 and set guidance for Q2.
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Cibus Reports Third Quarter Financial Results and Provides Business Update
Rice herbicide-tolerance traits performed well in Latin American field trials and are now being tested by customer Interoc in its own varietiesInitiated the manufacturing process for initial two biofragrance products; bi
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
AmpliTech Group, Inc. (AMPG) Expects 2026 Revenue of at Least $28M
AmpliTech reported Q3 2026 revenue of $6.58M, up 8.0% year over year, and gross margin of 34.2%. It expects full-year 2026 revenue of at least $28M after withdrawing its prior $50M target.Material DetailsContext by AI An
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Beeline Holdings, Inc. (BLNE) Q3 Revenue Rises 30% Year Over Year
Beeline reported Q3 2026 revenue growth of 30% year over year; net loss decreased 6% and adjusted EBITDA loss narrowed 33% sequentially. The proposed TYTL acquisition is subject to shareholder approval and closing condit
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027
SAN ANTONIO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm1 with longstanding experience in global markets and specialized sectors, to
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
ProMIS Neurosciences Announces Third Quarter 2026 Financial Results and Reaffirms First Quarter 2027 Topline Data Timing
Cambridge, Massachusetts, Nov. 12, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. NASDAQ:PMN, a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic
EQUITY | Nov 12, 2026, 09:13 PM UTC
H
Dyadic Announces Third Quarter 2026 Financial Results and Recent Developments
Advances Commercialization, Expands Strategic Partnerships and Accelerates Biopharmaceutical Platform ValidationDyadic to host earnings call on November 12, 2026, at 5:00 p.m. ETJUPITER, Fla., Nov. 12, 2026 (GLOBE NEWSWI
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
CV Sciences Q3 revenue falls 7% amid regulatory pressure
CV Sciences Q3 revenue falls 7% amid regulatory pressure Overview US hemp wellness firm's Q3 revenue
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
SHIMMICK CORP - EXPECTS FY2026 CONSOLIDATED REVENUE $500 MLN-$525 MLN
SHIMMICK CORP - EXPECTS FY2026 CONSOLIDATED REVENUE $500 MLN-$525 MLN
EARNINGS | Nov 12, 2026, 09:13 PM UTC
M
Applied Materials shares rise 2% in extended trading
Shares rose 2% after the quarterly report.
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Arcadia Biosciences Q3 revenue rises 24% to record high
Arcadia Biosciences Q3 revenue rises 24% to record high Overview Wellness products maker's Q3 revenu
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Armata Pharmaceuticals Q3 2026 swings to net profit of $54.86 million
Armata Pharmaceuticals Q3 2026 swings to net profit of $54.86 million Armata Pharmaceuticals swu
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
CORAL GABLES, Fla., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
MDxHealth's Q3 revenue misses expectations due to disrupted commercial execution
MDxHealth's Q3 revenue misses expectations due to disrupted commercial execution Overview Precision
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Anthropic’s IPO Said To Be About Six Times Oversubscribed
READ HERE
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Wealthfront to Announce Fiscal Third Quarter 2027 Financial Results on December 3, 2026
PALO ALTO, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Wealthfront Corporation NASDAQ:WLTH, a tech-driven financial platform helping digital natives turn their savings into wealth, today announced that it will release fisc
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Park Dental Partners Announces Third Quarter 2026 Results
MINNEAPOLIS, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. NASDAQ:PARK and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its third quarter financi
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
Birchtech Corp. (BCHT) Reports $5.5M Product Revenue, Down From $7.4M Total Revenue
Q3 2026 revenue was $5.5M versus $7.4M a year earlier, including $5.5M in product revenue, up 15.7% from $4.7M. Net loss was $0.3M versus net income of $0.8M; prior-year revenue included $2.6M in one-time license fees.Ma
EARNINGS | Nov 12, 2026, 09:13 PM UTC
H
Codexis (CDXS) Reports $19.3M in Q3 Revenue and Reiterates 2026 Revenue Guidance
Codexis reported Q3 2026 revenue of $19.3M and reiterated full-year revenue guidance. It entered a $60M term loan facility, using $42.5M to refinance existing debt; no prior-period revenue comparison was provided.Materia
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Arcadia Biosciences (RKDA) Q3 Revenue Rose 24%; Net Income Included $2.6M Valuation Gain
Q3 2026 revenue increased $317.0K, or 24%, year over year. Net income was $1.8M versus $856.0K, primarily reflecting a $2.6M gain from changes in estimated warrant and option liability fair value.Material DetailsContext
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
SELLAS Life Sciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Topline Primary Endpoint Results of the Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia Following the 80th Event to Report this Month -- 40 Patients Enrolled in Phase 2 Trial of SLS009 in Newly Diag
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
INNOVATE Corp. Announces Third Quarter 2026 Results
Infrastructure: INNOVATE completes sale of DBM Global to IES Holdings- Life Sciences: MediBeacon continues to advance U.S. commercialization efforts, while progressing key reimbursement initiatives- Spectrum: INNOVATE cl
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
WidePoint Corporation (WYY) Reports Q3 Results; Task Orders Valued at ~$33.7M
WidePoint reported third-quarter 2026 results, but the release text provides no financial figures. It received 40 new and replacement task orders valued at approximately $33.7M and submitted a revised proposal for the pe
EQUITY | Nov 12, 2026, 09:13 PM UTC
H
Beeline Q3 2026 Revenue Increases 30% Year-Over-Year; Net Loss Decreases 6% and Adjusted EBITDA Loss Narrows 33% Sequentially
Proposed TYTL Acquisition Expected to Finalize Definitive Agreements Within Days Positioning Beeline as a Leader in AI-Powered, Blockchain-Enabled Real Estate FinanceCEO to Cancel 3 Million TYTL Merger Shares Upon Closin
CRYPTO | Nov 12, 2026, 09:13 PM UTC
L
Snail, Inc. (SNAL) Q3 Revenue Rose 139.2% to $33.1M; Net Income Was $6.7M
Third-quarter revenue rose 139.2% to $33.1M from $13.8M a year earlier, while net income was $6.7M versus a $7.9M loss. Bookings increased 30.4% to $23.0M from $17.6M.Material DetailsContext by AI AnalystThis is a quarte
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Equillium (EQ) Reports $4.6M Q3 Net Loss; Cash Runway Expected Into 2029
Equillium reported a Q3 2026 net loss of $4.6M, versus $4.2M in Q3 2025. Cash was $53.3M at September 30, 2026; after approximately $20M gross financing in October, pro forma cash was approximately $72.0M, with runway ex
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
ADARx Appoints Ying Huang to Board
ADARx Pharmaceuticals appointed Ying Huang, CEO, to its board of directors.
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
AmpliTech Group Reports Q3 2026 Revenue of $6.58 Million, Up 8.0% Year-over-Year, and 41.1% Nine-Month Gross Profit Growth
Q3 Gross Margin Expands Sequentially to 34.2%; Previously Announced Backlog Surpassed $52 Million in October. Secures Approved Supplier Status with a Leading Global Telecommunications Equipment ManufacturerHAUPPAUGE, N.Y
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Spero Therapeutics Announces Third Quarter 2026 Operating Results and Provides Business Update
CAMBRIDGE, Mass., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. NASDAQ:SPRO, a clinical-stage biopharmaceutical company focused on advancing next-generation medicines for immune-mediated diseases, today anno
EQUITY | Nov 12, 2026, 09:13 PM UTC
L
CapsoVision, Inc. (CV) Q3 Revenue Rises to $3.6M; Net Loss Narrows to $7.3M
Q3 2026 revenue was $3.6M versus $3.5M a year earlier; net loss was $7.3M, or $0.15 per share, versus $7.9M, or $0.17. Gross margin fell to 49% from 54%; cash was $21.8M at quarter-end.Material DetailsContext by AI Analy
EARNINGS | Nov 12, 2026, 09:13 PM UTC
L
Accelevation Holdings Corp. (ACCV) Reports 66% Revenue Growth in Q3
Accelevation reported 66% revenue growth and bookings growth of over 350% in Q3 2026. Backlog was approximately $1.7B, operating cash flow exceeded $62M, and Adjusted EBITDA margin approached 19%; prior-period comparison
EARNINGS | Nov 12, 2026, 09:13 PM UTC
M
Cerebras Reports Q3 Revenue of $210.8 Million
Cerebras Systems reported Q3 revenue of $210.8 million, compared with a FactSet estimate of $214.7 million.
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
State Street Insider Sold Shares Worth $1,119,266, SEC Filing Shows
An SEC filing reports that State Street Executive Vice President Kathryn M Horgan sold shares on November 1.
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Arcadia Biosciences (RKDA) Announces Third Quarter 2026 Financial Results and Business Highlights
Zola® Q3 revenues increase 24% year-over-year, largest quarterly sales ever ---- New 1L espresso formulation ships this month, slim cans to launch in early 2027 --DALLAS, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Bioscie
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
CapsoVision Reports Third Quarter 2026 Financial Results
SARATOGA, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. NASDAQ:CV, a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financ
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Listed on the Nasdaq Global Market under the ticker symbol “SCTX,” and raised capital to fund the initial clinical development of STX-1150, STX-1200, and STX-1400Continued enrollment in first-in-human Phase 1 clinical tr
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Birchtech Reports Third Quarter 2026 Financial Results
Third Quarter 2026 Product Revenues Grew 15.7% Year-over-Year to $5.5 Million; Appellee Brief Filed with the Federal Circuit in Support of the $78 Million Final Judgment; Shares Repurchased Under $5.0 Million ProgramCORS
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
NeuroPace Q3 net loss from continuing operations narrows 33% year over year to $3.3 million
NeuroPace Q3 net loss from continuing operations narrows 33% year over year to $3.3 million Neur
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Rekor Systems, Inc. (REKR) Q3 Revenue Fell 23% to $10.9M
Q3 revenue fell 23% to $10.9M from $14.2M, while recurring revenue rose 16% year over year to $7.5M. Nine-month operating cash use fell 49% year over year; the $15.0M notes mature Dec. 15, 2026, and refinancing remains s
RATES | Nov 12, 2026, 09:12 PM UTC
L
INTER & CO Q3 NET PROFIT 425 MLN REAIS VS IBES ESTIMATE 425 MLN REAIS
INTER & CO Q3 NET PROFIT 425 MLN REAIS VS IBES ESTIMATE 425 MLN REAIS
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
INTER & CO Q3 NET PROFIT 425 MLN REAIS VS IBES ESTIMATE 425 MLN REAIS
INTER & CO Q3 NET PROFIT 425 MLN REAIS VS IBES ESTIMATE 425 MLN REAIS
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Codexis Reports Third Quarter 2026 Financial Results and Provides Business Update
Reports revenue of $19.3 million for the third quarter of 2026, company reiterates full-year revenue guidanceShared new advances in RNA therapeutic manufacturing at TIDES EuropeEntered into a $60 million term loan facili
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Fractyl Health Reports Third Quarter 2026 Financial Results and Business Updates
REMAIN-1 Pivotal Cohort met its six-month co-primary endpoint with high statistical significance (p=0.0023); Revita® participants retained approximately 80% of GLP-1-induced weight loss versus 67% for shamPlanned FDA De
REGULATION | Nov 12, 2026, 09:12 PM UTC
L
WidePoint Reports Third Quarter 2026 Financial Results
FAIRFAX, Va., Nov. 12, 2026 (GLOBE NEWSWIRE) -- WidePoint Corporation (NYSE American: WYY), a leading provider of Secure Mobility Management solutions, reported results for the third quarter ended September 30, 2026.Thir
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Snail, Inc. Reports Third Quarter 2026 Financial Results
CULVER CITY, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Snail, Inc. NASDAQ:SNAL (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today announced
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
4D Molecular Therapeutics (FDMT) Reports $78.1M Q3 Net Loss
Q3 2026 net loss was $78.1M versus $56.9M in Q3 2025. Cash, cash equivalents and marketable securities totaled $375.0M at September 30, 2026, versus $514.0M at December 31, 2025; the company estimates funding into at lea
EQUITY | Nov 12, 2026, 09:12 PM UTC
M
PRF Technologies Requests Hearing on Nasdaq Delisting Determination
The company says its hearing request stays any suspension or delisting action, and its ordinary shares will continue trading on the Nasdaq Capital Market pending the Hearings Panel’s decision.
REGULATION | Nov 12, 2026, 09:12 PM UTC
M
Cerebras Systems Raises FY Core Revenue Outlook to $940M–$960M
Cerebras Systems now forecasts fiscal-year core revenue of $940 million to $960 million, versus its prior forecast of $880 million to $890 million.
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Merlin, Inc. (MRLN) Ends Q3 With $161.6M in Cash and No Debt
Merlin ended Q3 2026 with $161.6M in cash, cash equivalents and short-term investments, and no debt. It expects 2027 operating expenses to be meaningfully below 2026 levels; no comparison figures were provided.Material D
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
VirTra, Inc. (VTSI) Q3 Revenue Rose 42% to $7.6M; Net Income Was $2.2M
Q3 2026 revenue rose 42% year over year to $7.6M, and net income was $2.2M versus a $0.4M loss. Nine-month revenue was $16.9M versus $19.5M a year earlier.Material DetailsContext by AI AnalystThe results show a sharp Q3
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates
Completed initial public offering (IPO) and concurrent private placement generating aggregate gross proceeds of approximately $602.5 million; cash position expected to fund operations into 2030 —— Advanced three Phase 2
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Equillium Reports Third Quarter 2026 Financial Results and Recent Corporate and Clinical Highlights
First participant dosed in Phase 1 clinical trial of EQ504, proof-of-mechanism data expected in Q2 2027Cash equivalents of $53.3 million as of September 30, 2026; pro forma cash balance of approximately $72.0 million aft
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Mannatech Q3 net sales fall 14.6%, operating income declines
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Crown Crafts, Inc. (CRWS) Q2 Sales Fall 20%, Net Income Rises to $1.3M
Crown Crafts reported Q2 fiscal 2027 net sales of $19.0M versus $23.7M a year earlier. Net income rose to $1.3M, or $0.12 per diluted share, from $1.2M, or $0.11.Material DetailsContext by AI AnalystThis quarter shows im
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Merlin, Inc. Reports Third Quarter 2026 Results
Ended Third Quarter 2026 With $161.6 Million in Cash, Cash Equivalents, and Short Term Investments, and No DebtBOSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Merlin, Inc. NASDAQ:MRLN, an aerospace and defense technology compa
EQUITY | Nov 12, 2026, 09:12 PM UTC
H
Accelevation Holdings Corp. Reports Strong Third Quarter 2026 with Revenue Growth of 66%, Bookings Growth of over 350%, and Robust Cash Gene
Third Quarter 2026 Business HighlightsFull Year 2026 Guidance***Amounts are non-GAAP financial measures. See the schedules below for a discussion of non-GAAP financial metrics including a reconciliation to the most direc
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Chevron Vice Chairman Mark A. Nelson Reports $23.57 Million Share Sale
Chevron Vice Chairman Mark A. Nelson reported selling $23.57 million in common shares.
EQUITY | Nov 12, 2026, 09:12 PM UTC
M
Applied Materials Posts Q4 Adjusted EPS of $4.16 Per Share
EARNINGS | Nov 12, 2026, 09:12 PM UTC
M
Bolt Biotherapeutics Completes Prana Acquisition and Raises $120 Million
Bolt completed its stock-for-stock acquisition of Prana Therapies in October and closed a concurrent $120 million private placement. Prana’s PRA-216 is in Phase 2 across asthma, COPD and atopic dermatitis; a fourth study
MNA | Nov 12, 2026, 09:12 PM UTC
L
VirTra Reports Third Quarter and Nine Months 2026 Financial Results
CHANDLER, Ariz., Nov. 12, 2026 (GLOBE NEWSWIRE) -- VirTra, Inc. NASDAQ:VTSI (“VirTra” or the “Company”), a global provider of judgmental use-of-force and firearms training simulators, reported results for the third quart
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
4DMT Reports Third Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
EMERYVILLE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with the
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Shimmick Corporation Announces Third Quarter 2026 Results
IRVINE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Shimmick Corp. NASDAQ:SHIM, a leading infrastructure solutions provider in water, electrical and other critical infrastructure construction services, today announced fina
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Mannatech Q3 net sales fall 14.6%, operating income declines
Mannatech Q3 net sales fall 14.6%, operating income declines Overview US health and wellness firm's
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
REDWOOD CITY, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. NASDAQ:BOLT, a clinical-stage biotechnology company advancing next-generation, half-life-extended multispecific antibodies, today reporte
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Newsmax Q3 net income swings to $15.23 million; Q3 revenue rises 53% to $69 million
Newsmax Q3 net income swings to $15.23 million; Q3 revenue rises 53% to $69 million Newsmax swun
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
ROC Delivers Record Quarterly Revenue of $8.0 Million in the Third-Quarter 2026, Up 50% YoY; Achieves Quarterly Profitability
Product revenue grew 24% to $5.7 million, driven by strong software licensing performance; gross margin reached 90% for the second consecutive quarterMeasurable results validate ROC’s core growth drivers; ROC ABIS grew 6
EARNINGS | Nov 12, 2026, 09:12 PM UTC
M
Applied Materials Sees 1Q Revenue of $11.1B ± $500M
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Rekor Systems Reports Third Quarter 2026 Financial Results
Recurring Revenue Grew 16% to $7.5 Million; Nine-Month Operating Cash Use Cut 49% as Rekor Completes Major Rightsizing and Builds Foundation for 2027 GrowthCOLUMBIA, Md., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Rekor Systems,
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Inuvo 3Q Loss/Shr 28c >INUV
Inuvo 3Q Loss/Shr 28c >INUV
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Inuvo Third Quarter 2026 Results Reflect Inflection Point as IntentKey Pipeline Builds
IntentKey’s Privacy-By-Design Value Proposition Resonates as Sales Pipeline Builds Legacy Search Rev
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
INUVO Q3 NET INCOME USD -5 MILLION
INUVO Q3 NET INCOME USD -5 MILLION
FX | Nov 12, 2026, 09:12 PM UTC
L
INUVO Q3 EPS USD -0.28
INUVO Q3 EPS USD -0.28
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
INUVO Q3 GROSS MARGIN 44%
INUVO Q3 GROSS MARGIN 44%
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
INUVO Q3 REVENUE USD 6.8 MILLION
INUVO Q3 REVENUE USD 6.8 MILLION
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
INUVO THIRD QUARTER 2026 RESULTS REFLECT INFLECTION POINT AS INTENTKEY PIPELINE BUILDS
INUVO THIRD QUARTER 2026 RESULTS REFLECT INFLECTION POINT AS INTENTKEY PIPELINE BUILDS
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Crown Crafts Announces Financial Results for Second Quarter Fiscal 2027
GONZALES, La., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) a producer, designer, and distributor of infant, toddler, and juvenile consumer products, today reported results for t
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Inuvo Third Quarter 2026 Results Reflect Inflection Point as IntentKey Pipeline Builds
Inuvo Third Quarter 2026 Results Reflect Inflection Point as IntentKey Pipeline Builds IntentKey’s P
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Gaxos.ai Inc. (GXAI) Q3 Revenue Rose 14.5% Sequentially and 464.9% YoY
Gaxos reported Q3 revenue of approximately $2.81M, up 14.5% from Q2 2026 and 464.9% from Q3 2025. Advertising and marketing expense fell approximately 16.7% sequentially to $2.62M.Material DetailsContext by AI AnalystThi
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Sellas Life Sciences Q3 Net Loss Widens 49% to $10.09 Million
Sellas Life Sciences Q3 Net Loss Widens 49% to $10.09 Million Sellas Life Sciences’ third-quarte
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Motorola Solutions CEO Sold 40,000 Shares Worth $21 Million
Gregory Q. Brown sold 40,000 shares on November 9, 2026, at a weighted average price of approximately $525.16 per share, for total proceeds of $21,006,423. He directly owned 66,768 shares after the transactions.
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Once Upon a Farm Updating 2026 Net Sales and Adjusted EBITDA Outlook >OFRM
Once Upon a Farm Updating 2026 Net Sales and Adjusted EBITDA Outlook >OFRM
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Tenon Medical, Inc. (TNON) Q3 Revenue Rose 22% to $1.4M; Net Loss Widened
Third-quarter 2026 revenue rose 22% year over year to $1.4M, while net loss increased to $6.6M from $3.3M. Tenon raised approximately $15.6M in gross proceeds, repaid its convertible notes in full and ended the quarter w
RATES | Nov 12, 2026, 09:12 PM UTC
H
United States Antimony Corporation (UAMY) Q3 Revenue Rises 16% to $10.1M; Net Loss Widens to $9.5M
Q3 2026 revenue rose 16% year over year to $10.1M, while net loss widened to $9.5M from $4.8M. The company withdrew its 2026 revenue guidance and expects antimony sales of 1.68M—1.81M pounds, up approximately 24% at the
EARNINGS | Nov 12, 2026, 09:12 PM UTC
H
Newsmax Inc. (NMAX) Reports Q3 Revenue of $69.0M, Up 52.5% YoY
Newsmax reported Q3 2026 revenue of $69.0M, up 52.5% year over year, net income of $15.2M and Adjusted EBITDA of $19.0M. Excluding a $14.0M one-time revenue item, revenue grew 21.6%; underlying FY2026 revenue guidance re
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Virgin Galactic Q3 net loss narrows 9% to $58.76 million
Virgin Galactic Q3 net loss narrows 9% to $58.76 million Virgin Galactic’s third-quarter 2026 ne
EQUITY | Nov 12, 2026, 09:12 PM UTC
H
dLocal Limited (DLO) Q3 Revenue Rose 41% To $398M
dLocal Limited reported Q3 2026 revenue of $398M, up 41% year over year, and net income of $68M, up 31%. TPV was $18.3B, up 77% year over year; these quarterly financial results were unaudited.Material DetailsContext by
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Peraso Appoints Kevin Liu Interim CFO Effective November 18
Kevin Liu succeeds CEO Ronald Glibbery, who served as interim CFO since October 2, 2026 and will remain CEO.
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Canadian natural gas producer Birchcliff posts Q3 net income
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
ENERGY | Nov 12, 2026, 09:12 PM UTC
L
South Korea Export Price Index (M/M) Oct: 0.7% (prev -0.8%; prevR -0.5%)
Export Price Index (Y/Y): 36.7% (prev 40.9%; prevR 41.3%) - Import Price Index (M/M): 1-.8% (prev 1.7%; prevR 1.9%) - Import Price Index (Y/Y): 13.5% (prev 17.6%; prevR 17.8%)
NEWS | Nov 12, 2026, 09:12 PM UTC
L
STERIS filing says proceeds will fund Xodus Medical acquisition and expenses
MNA | Nov 12, 2026, 09:12 PM UTC
L
Gaxos Reports Third-Quarter Revenue Growth of 14.5% Sequentially and 464.9% Year over Year
Advertising and marketing expense decreases 16.7% sequentially as revenue per dollar of advertising and marketing expense improves approximately 38%Roseland, NJ, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" o
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Once Upon a Farm 3Q Sales $89.1M >OFRM
Once Upon a Farm 3Q Sales $89.1M >OFRM
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Intrusion Inc. (INTZ) Q3 Revenue Rose 36% to $2.7M; Net Loss Widened to $2.9M
Q3 2026 revenue was $2.7M, up 36% year over year and 84% sequentially. Net loss attributable to Intrusion was $2.9M, or $0.12 per share, versus $2.1M, or $0.10 per share, a year earlier.Material DetailsContext by AI Anal
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Peraso Inc. (PRSO) Q3 Revenue Fell to $0.3M; October Order Exceeded $2M
Q3 2026 revenue was $0.3M versus $3.2M a year earlier, and GAAP net loss was $2.7M versus $1.2M. In October, Peraso received a production order exceeding $2M, its largest FWA order in six quarters.Material DetailsContext
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
US Global Investors 1Q Rev $2.66M >GROW
US Global Investors 1Q Rev $2.66M >GROW
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
CISCO SYSTEMS INC FY2027 SHR VIEW $5.11, REV VIEW $73.02 BLN -- LSEG IBES DATA
CISCO SYSTEMS INC FY2027 SHR VIEW $5.11, REV VIEW $73.02 BLN -- LSEG IBES DATA
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Canadian natural gas producer Birchcliff posts Q3 net income
Canadian natural gas producer Birchcliff posts Q3 net income Overview Canada natural gas producer's
ENERGY | Nov 12, 2026, 09:12 PM UTC
L
dLocal Reports Third Quarter 2026 Financial Results
TPV reached US$18 billion (+77% year-over-year), marking the 8th consecutive quarter of 50%+ year-over-year growth. Revenue reached US$398 million (+41% year-over-year), with gross profit of US$132 million (+28% year-ove
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Once Upon a Farm 3Q Loss $3.81M >OFRM
Once Upon a Farm 3Q Loss $3.81M >OFRM
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Peraso Appoints Kevin Liu as Interim Chief Financial Officer
Peraso said Kevin Liu will become interim CFO on November 18, 2026.
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Once Upon a Farm 3Q Loss/Shr 9c >OFRM
Once Upon a Farm 3Q Loss/Shr 9c >OFRM
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
SHIMMICK CORP Q3 ADJUSTED EPS USD 0.08
SHIMMICK CORP Q3 ADJUSTED EPS USD 0.08
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
Tenon(R) Medical Reports Third Quarter 2026 Financial Results
~ Third Quarter 2026 Revenue of $1.4 Million, a 22% Increase Compared to Prior Year ~~ Third Quarter Gross Profit of $1.0 Million, a 23% Increase Compared to Prior Year; Gross Margin of 66.3% ~~ Raised Approximately $15.
RATES | Nov 12, 2026, 09:12 PM UTC
L
HeartBeam Q3 net loss narrows as operating expenses fall
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Intrusion Inc. Reports Third Quarter 2026 Results
Revenue growth reflects first full quarter of VigilAigent contribution and continued stabilization of the legacy businessPLANO, TX / / November 12, 2026 / Intrusion Inc. NASDAQ:INTZ ("Intrusion" or the "Company"), a prov
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
United States Antimony Corporation Reports Third Quarter and Nine Months Ended September 30, 2026 Financial and Operating Results
Third Quarter 2026 Revenues Increased 16% to $10.1 MillionAntimony pounds sold up 68% in the quarterGross Profit Margin Expands to 42% from 23%Gross Profit up 113% to $4.3 MillionProjected 2026 Antimony Sales of 1.68-1.8
EARNINGS | Nov 12, 2026, 09:12 PM UTC
L
STERIS Prices $1.5 Billion Senior Notes Offering
The offering comprises $750 million due 2033 and $750 million due 2036.
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Newsmax Announces Third Quarter 2026 Financial Results
Company Reports Record Quarterly Revenues of $69.0 million, a 52.5% Year-Over-Year IncreaseCompany Reports Net Income of $15.2 million and Adjusted EBITDA of $19.0 millionCompany Updates Full-Year 2026 OutlookBOCA RATON,
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
Peraso Announces Third Quarter 2026 Results
SAN JOSE, CA / / November 12, 2026 / Peraso Inc. NASDAQ:PRSO ("Peraso" or the "Company"), a leader in high-performance 60 GHz wireless technology, today announced financial results for the third quarter ended September 3
EQUITY | Nov 12, 2026, 09:12 PM UTC
L
ON Semiconductor filing details $1.75 billion revolving credit facility
An SEC filing says an agreement provides ON Semiconductor with a $1.75 billion senior revolving credit facility.
EQUITY | Nov 12, 2026, 09:11 PM UTC
L
HeartBeam Q3 net loss narrows as operating expenses fall
HeartBeam Q3 net loss narrows as operating expenses fall Overview US cardiac diagnostics firm's Q3 n
EQUITY | Nov 12, 2026, 09:11 PM UTC
L
Lifeway Foods Q3 net income falls on higher input, transportation costs
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 09:11 PM UTC